Literature DB >> 10208437

Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN.

G H Fujii1, A M Morimoto, A E Berson, J B Bolen.   

Abstract

PTEN/MMAC1 is a recently characterized tumor suppressor. A pseudogene derived from the human PTEN/MMAC1 phosphatase, psiPTEN, has been reported. Recent analysis of the pseudogene revealed conflicting results about the expression of psiPTEN. In this study, we show that the PTEN/MMAC1 pseudogene is actively transcribed in all cells and tissues examined. In some cases, pseudogene transcripts were found to represent as much as 70% of the total PTEN/MMAC1 RNA. As psiPTEN is transcribed, there is a potential for misinterpretation of PTEN/MMAC1 mutations when RT-PCR techniques are used, as well as potential for a psiPTEN-encoded translation product. Although we were unable to detect a pseudogene protein product in the cell lines examined, a baculovirus produced GST pseudogene fusion protein exhibited phosphatase activity comparable to wild type. The results of this study, taken together, indicate the potential complication of PTEN/MMAC1 molecular analysis caused by the expression of psiPTEN.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208437     DOI: 10.1038/sj.onc.1202492

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Millions of years of evolution preserved: a comprehensive catalog of the processed pseudogenes in the human genome.

Authors:  Zhaolei Zhang; Paul M Harrison; Yin Liu; Mark Gerstein
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

2.  Identification and analysis of over 2000 ribosomal protein pseudogenes in the human genome.

Authors:  Zhaolei Zhang; Paul Harrison; Mark Gerstein
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

3.  Digging for dead genes: an analysis of the characteristics of the pseudogene population in the Caenorhabditis elegans genome.

Authors:  P M Harrison; N Echols; M B Gerstein
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

4.  Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?

Authors:  Yevgeniya J Ioffe; Katherine B Chiappinelli; David G Mutch; Israel Zighelboim; Paul J Goodfellow
Journal:  Gynecol Oncol       Date:  2011-10-15       Impact factor: 5.482

5.  Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs).

Authors:  Yijun Ruan; Hong Sain Ooi; Siew Woh Choo; Kuo Ping Chiu; Xiao Dong Zhao; K G Srinivasan; Fei Yao; Chiou Yu Choo; Jun Liu; Pramila Ariyaratne; Wilson G W Bin; Vladimir A Kuznetsov; Atif Shahab; Wing-Kin Sung; Guillaume Bourque; Nallasivam Palanisamy; Chia-Lin Wei
Journal:  Genome Res       Date:  2007-06       Impact factor: 9.043

6.  A transcribed pseudogene of MYLK promotes cell proliferation.

Authors:  Yoo Jeong Han; Shwu Fan Ma; Gregory Yourek; Yoon-Dong Park; Joe G N Garcia
Journal:  FASEB J       Date:  2011-03-25       Impact factor: 5.191

7.  Pseudogenes: Four Decades of Discovery.

Authors:  Leonardo Salmena
Journal:  Methods Mol Biol       Date:  2021

8.  Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.

Authors:  Hind Medyouf; Xiuhua Gao; Florence Armstrong; Samuel Gusscott; Qing Liu; Amanda Larson Gedman; Larry H Matherly; Kirk R Schultz; Francoise Pflumio; Mingjian James You; Andrew P Weng
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

9.  The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development.

Authors:  Jingyu Zhang; Xia Wang; Bing Chen; Zhifeng Xiao; Wenmei Li; Youyong Lu; Jianwu Dai
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

10.  Assessing the genomic evidence for conserved transcribed pseudogenes under selection.

Authors:  Amit N Khachane; Paul M Harrison
Journal:  BMC Genomics       Date:  2009-09-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.